# Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

> **NCT05737927** · PHASE1 · COMPLETED · sponsor: **Aphaia Pharma US LLC** · enrollment: 20 (actual)

## Conditions studied

- Obese

## Interventions

- **DRUG:** Glucose 8 g coated beads (47% w/w)
- **DRUG:** Glucose 12 g coated beads (47% w/w)
- **DRUG:** Glucose 16 g coated beads (47% w/w)
- **DRUG:** Glucose 12 g uncoated beads
- **DRUG:** Glucose 12 g coated beads (60% w/w)
- **DRUG:** Glucose 12 g coated beads (47% w/w)

## Key facts

- **NCT ID:** NCT05737927
- **Lead sponsor:** Aphaia Pharma US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-16
- **Primary completion:** 2020-11-09
- **Final completion:** 2020-11-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737927, "Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05737927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*